ARIH2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.780400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.513400E-01
Normal-vs-Stage2
2.179400E-01
Normal-vs-Stage3
5.903600E-02
Normal-vs-Stage4
9.219800E-01
Stage1-vs-Stage2
5.201600E-01
Stage1-vs-Stage3
1.192990E-01
Stage1-vs-Stage4
8.810600E-01
Stage2-vs-Stage3
3.035500E-02
Stage2-vs-Stage4
2.044400E-01
Stage3-vs-Stage4
7.784900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.187400E-01
Normal-vs-AfricanAmerican
5.977800E-01
Normal-vs-Asian
7.287900E-02
Caucasian-vs-AfricanAmerican
7.800000E-01
Caucasian-vs-Asian
6.889900E-02
AfricanAmerican-vs-Asian
1.707840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.514400E-01
Normal-vs-Female
3.381000E-01
Male-vs-Female
6.117800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.923600E-01
Normal-vs-Age(41-60Yrs)
4.182800E-01
Normal-vs-Age(61-80Yrs)
2.438200E-01
Normal-vs-Age(81-100Yrs)
8.798400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.548200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.456360E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.994000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.545900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.464440E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.921800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.605700E-02
Normal-vs-Daily Drinker
1.167610E-01
Normal-vs-Weekly Drinker
4.708000E-01
Normal-vs-Occasional Drinker
4.021600E-01
Normal-vs-Social Drinker
5.915400E-01
Non Drinker-vs-Daily Drinker
5.864400E-01
Non Drinker-vs-Weekly Drinker
1.403620E-01
Non Drinker-vs-Occasional Drinker
1.082040E-01
Non Drinker-vs-Social Drinker
4.004100E-02
Daily Drinker-vs-Weekly Drinker
3.059200E-01
Daily Drinker-vs-Occasional Drinker
2.709000E-01
Daily Drinker-vs-Social Drinker
1.149630E-01
Weekly Drinker-vs-Occasional Drinker
9.691400E-01
Weekly Drinker-vs-Social Drinker
6.907000E-01
Occasional Drinker-vs-Social Drinker
6.249200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.280600E-01
Normal-vs-Grade 2
7.722600E-01
Normal-vs-Grade 3
7.872600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.958400E-01
Grade 1-vs-Grade 3
4.079800E-01
Grade 1-vs-Grade 4
4.280600E-01
Grade 2-vs-Grade 3
7.698000E-01
Grade 2-vs-Grade 4
7.722600E-01
Grade 3-vs-Grade 4
7.872600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.306600E-01
Normal-vs-NonDiabetic
2.296600E-01
Diabetic-vs-NonDiabetic
6.794600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.151000E-01
Normal-vs-NoPancreatitis
2.407200E-01
Pancreatitis-vs-NoPancreatitis
8.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.142200E-01
Normal-vs-N1
2.058400E-01
N0-vs-N1
5.668600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.022800E-01
Normal-vs-TP53-NonMutant
7.188800E-01
TP53-Mutant-vs-TP53-NonMutant
1.508400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
